Evidence map›Paper›PMID 35487911›Full record

ArticleNature communications2022

Regulation of chromatin accessibility by the histone chaperone CAF-1 sustains lineage fidelity.

Reuben Franklin, Yiming Guo, Shiyang He, Meijuan Chen, Fei Ji, Xinyue Zhou, David Frankhouser, Brian T Do, Carmen Chiem, Mihyun Jang and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Stress triggers global histone synthesis in the liver.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Reuben FranklinDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States.ORCID 0000-0002-6513-3205
Yiming GuoDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States.
Shiyang HeDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States.ORCID 0000-0002-1849-2635
Meijuan ChenDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States.ORCID 0000-0001-6200-9404
Fei JiDepartment of Molecular Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, United States.
Xinyue ZhouDivision of Hematology/Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.
David FrankhouserDepartment of Population Sciences City of Hope National Medical Center, Duarte, CA, United States.ORCID 0000-0002-8233-5853
Brian T DoKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, United States.ORCID 0000-0003-4992-2623
Carmen ChiemDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States.
Mihyun JangDepartment of Computational and Quantitative Medicine, Division of Mathematical Oncology, City of Hope National Medical Center, Duarte, CA, United States.
M Andres BlancoDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Matthew G Vander HeidenKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, United States.ORCID 0000-0002-6702-4192
Russell C RockneDepartment of Computational and Quantitative Medicine, Division of Mathematical Oncology, City of Hope National Medical Center, Duarte, CA, United States.ORCID 0000-0002-1557-159X
Maria NinovaDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States.ORCID 0000-0001-5051-5502
David B SykesCenter for Regenerative Medicine, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, United States.
Konrad HochedlingerDepartment of Molecular Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, United States.ORCID 0000-0001-5811-5386
Rui LuDivision of Hematology/Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.ORCID 0000-0003-1593-2612
Ruslan I SadreyevDepartment of Molecular Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA, 02114, United States.
Jernej MurnDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States. jernej.murn@ucr.edu.ORCID 0000-0002-1729-5859
Andrew VolkExperimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. andrew.volk@cchmc.org.ORCID 0000-0003-2133-7940
Sihem CheloufiDepartment of Biochemistry, University of California, Riverside, 3401 Watkins Drive, Boyce Hall, Riverside, CA, 92521, United States. sihem.cheloufi@ucr.edu.ORCID 0000-0002-1726-4796
University of California, Riverside · USCity Of Hope National Medical Center · USHarvard–MIT Division of Health Sciences and Technology · USHarvard University · USMassachusetts General Hospital · USUniversity of Alabama at Birmingham · USCincinnati Children's Hospital Medical Center · USUniversity of Pennsylvania · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Understanding the role of metabolism in cancerR35CA242379 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VANDER HEIDEN, MATTHEW G. · 2019 to 2025
$5.8M
Transcription Factor Induced ReprogrammingR01HD058013 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI HOCHEDLINGER, KONRAD · 2010 to 2019
$4.4M
Analysis of cancer cell metabolism in diverse environmental conditionsR01CA201276 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI VANDER HEIDEN, MATTHEW G., VITKUP, DENNIS · 2016 to 2020
$3.0M
How CHAF1B maintains cell state by repressing transcription of fate genesR35GM142452 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI VOLK, ANDREW · 2021 to 2025
$2.0M
MEF2D-Mediated Transcriptional Control of Acute Myeloid LeukemiaR01CA259480 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Rui Lu · 2022 to 2026
$1.7M
Elucidating the role of SUMO ligase Su(var)2-10 in piRNA-guided transcriptional silencing and repressive chromatin formationR00HD099316 · NICHD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NINOVA, MARIA ANTONINOVA · 2021 to 2023
$712k
The Role of CHAF1B in Maintaining Malignant Leukemia Stem CellsR00CA230314 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI VOLK, ANDREW · 2020 to 2022
$693k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA014051NCI NIH HHS P30 CA033572NCI NIH HHS P30 CA062203NCI NIH HHS R00 CA230314NCI NIH HHS R01 CA201276NCI NIH HHS R01 CA259480NCI NIH HHS R35 CA242379NCRR NIH HHS S10 RR025496NHLBI NIH HHS F30 HL156404NICHD NIH HHS K99 HD099316NICHD NIH HHS R00 HD099316NICHD NIH HHS R01 HD058013NIDDK NIH HHS P30 DK040561NIGMS NIH HHS R35 GM142452NIGMS NIH HHS T32 GM007753NIH HHS S10 OD010794NIH HHS S10 OD021718
6 · The paper itself

Abstract

Cell fate commitment is driven by dynamic changes in chromatin architecture and activity of lineage-specific transcription factors (TFs). The chromatin assembly factor-1 (CAF-1) is a histone chaperone that regulates chromatin architecture by facilitating nucleosome assembly during DNA replication. Accumulating evidence supports a substantial role of CAF-1 in cell fate maintenance, but the mechanisms by which CAF-1 restricts lineage choice remain poorly understood. Here, we investigate how CAF-1 influences chromatin dynamics and TF activity during lineage differentiation. We show that CAF-1 suppression triggers rapid differentiation of myeloid stem and progenitor cells into a mixed lineage state. We find that CAF-1 sustains lineage fidelity by controlling chromatin accessibility at specific loci, and limiting the binding of ELF1 TF at newly-accessible diverging regulatory elements. Together, our findings decipher key traits of chromatin accessibility that sustain lineage integrity and point to a powerful strategy for dissecting transcriptional circuits central to cell fate commitment.

Indexed as

ChromatinHistone ChaperonesChromatin Assembly Factor-1ChromosomesHistonesChromatinChromatin Assembly Factor-1Histone ChaperonesHistones

Identifiers

PMID35487911
PMCPMC9054786
OpenAlexW4225163237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.